AT2 Intrinsic Valuation and Fundamental Analysis - Atara Biotherapeutics Inc

A	Atara Biotherapeutics Inc F:AT2	US
S	Santos Ltd F:STS1	AU

Intrinsic Value

The intrinsic value for Atara Biotherapeutics Inc (AT2) under the Base Case is 39.74 EUR. Compared with the current market price of 9.25 EUR, the stock appears Undervalued by 77% .

DCF Value

€35.33

Multiples-Based Value

€44.14

DCF Value

€35.33

Multiples-Based Value

€44.14

Both DCF and multiples point to undervaluation.

Why combine DCF with multiples? What is Intrinsic Value?

AT2 Intrinsic Value

Undervaluation 77%

Intrinsic Value

Price €9.25

Base Case Scenario

Track Buy Zone

20% below Intrinsic Value €31.79

Get notified when the price drops into your buy zone

Intrinsic Value €39.74

Margin of Safety 20% €31.79

Current Price €9.25

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Atara Biotherapeutics Inc.

Explain Valuation